Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma

Pathology International

Volumn 59, Issue 7, 2009, Pages 431-437

  Imai, Hiroshi ^a   Shimada, Kazuyuki ^b   Shimada, Satoko ^c   Abe, Masato ^d   Okamoto, Masataka ^e   Kitamura, Kunio ^f   Kinoshita, Tomohiro ^b   Shiraishi, Taizo ^g   Nakamura, Sigeo ^c  

^a MIE UNIVERSITY HOSPITAL   (Japan)

^b Department of Hematology and Oncology ^*  (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

^e FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f Ichinomiya Municipal Hospital   (Japan)

^g MIE UNIVERSITY   (Japan)

Author keywords

CD5; Intravascular large B cell lymphoma; Primary central nervous system diffuse large B cell lymphoma

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; INTERFERON REGULATORY FACTOR 4; PROTEIN BCL 6; PROTEIN BNIP3;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B CELL LYMPHOMA; CELL MIGRATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; JAPANESE; LYMPHOMA CELL; MALE; NEUROLOGIC DISEASE; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SURVIVAL RATE;

AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 67650786758     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2009.02390.x     Document Type: Article

References (24)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. Lyon : IARC Press, 2001.
2. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large b-cell lymphoma identified by gene expression profiling. Nature 2000 403 : 503 11.
3. Swerdlow SH, Campo E, Harris NL et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon : IARC, 2008.
4. Hochberg FH, Baehring JM, Hochberg EP. Primary CNS lymphoma. Nat Clin Pract Neurol 2007 3 : 24 35. (Pubitemid 46056031)
5. Batchelor T, Loeffler JS. Primary CNS lymphoma. J Clin Oncol 2006 24 : 1281 8.
6. Louis DN, Ohgaki H, Weistler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC, 2007.
7. Camilleri-Broët S, Crinière E, Broët P et al. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: Analysis of 83 cases. Blood 2006 107 : 190 96.
8. Bhagavathi S, Sharathkumar A, Hunter S et al. Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas. Clin Neuropathol 2008 27 : 13 20. (Pubitemid 351156084)
9. Murase T, Yamaguchi M, Suzuki R et al. Intravascular large B-cell lymphoma (IVLBCL): A clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 2007 109 : 478 85.
10. Yamaguchi M, Seto M, Okamoto M et al. De novo CD5+ diffuse large B-cell lymphoma: A clinicopathologic study of 109 patients. Blood 2002 99 : 815 21.
11. Imai H, Kajimoto K, Taniwaki M et al. Intravascular large B-cell lymphoma presenting with mass lesions in the central nervous system: A report of five cases. Pathol Int 2004 54 : 231 6.
12. Shimada K, Matsue K, Yamamoto K et al. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 2008 26 : 3189 95.
13. Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004 103 : 275 82.
14. Murase T, Nakamura S, Kawauchi K et al. An Asian variant of intravascular large B-cell lymphoma: Clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 2000 111 : 826 34.
15. Ferreri AJ, Campo E, Seymour JF et al. Intravascular lymphoma: Clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol 2004 127 : 173 83.
16. Jahnke K, Thiel E, Martus P et al. Relapse of primary central nervous system lymphoma: Clinical features, outcome and prognostic factors. J Neurooncol 2006 80 : 159 65.
17. O'Neill BP, Dinapoli RP, Kurtin PJ, Habermann TM. Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): How much staging is enough? J Neurooncol 1995 25 : 67 71.
18. Ferreri AJ, Reni M, Zoldan MC, Terreni MR, Villa E. Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion. Cancer 1996 77 : 827 33.
19. Jahnke K, Hummel M, Korfel A et al. Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes. J Clin Oncol 2006 24 : 4754 7.
20. Alderson L, Fetell MR, Sisti M, Hochberg F, Cohen M, Louis DN. Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry 1996 60 : 102 5.
21. Bashir R, Coakham H, Hochberg F. Expression of LFA-1/ICAM-1 in CNS lymphomas: Possible mechanism for lymphoma homing into the brain. J Neurooncol 1992 12 : 103 10.
22. Smith JR, Braziel RM, Paoletti S et al. Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood 2003 101 : 815 21.
23. Rubenstein JL, Fridlyand J, Shen A et al. Gene expression and angiotropism in primary CNS lymphoma. Blood 2006 107 : 3716 23.
24. Tun HW, Personett D, Baskerville KA et al. Pathway analysis of primary central nervous system lymphoma. Blood 2008 111 : 3200 10.